Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

Poster

Selective targeting and protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease

See Poster
Poster

Rational design of a vaccine for Alzheimer’s disease using a computationallyderived conformational epitope to selectively target toxic amyloid-beta oligomers

See Poster
Presentation

AAN 2023 Presentation – Rational design of a vaccine for Alzheimer’s disease using computationally-derived conformational B cell epitopes to selectively target toxic amyloid-beta oligomers

View Presentation
Poster

AAN 2023 Poster – RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP

See Poster
Poster

AAN 2023 Poster – Protection against toxic amyloid-beta oligomers by PMN310 in Alzheimer’s disease

See Poster
Poster

AD/PD 2023 Poster

See Poster
Manuscript

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein

View Manuscript
Manuscript

A Rationally Designed Humanized Antibody selective for Amyloid Beta oligomers in Alzheimer’s

View Manuscript
Manuscript

Supplemental Section - A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease

View Manuscript
Poster

AAIC 2022 Poster - Distinguishing between amyloid-beta-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

See Poster
Poster

AAN 2022 Poster - RACK1 Knockdown Alleviates TDP-43 Associated Global Translational Suppression in vitro, and Neurodegeneration in vivo

See Poster
Presentation

NDD 2022 Presentation - Selective Antibody Targeting of Pathogenic Proteins: maximizing target engagement, minimizing target distraction

View Presentation